Recall
FDAHealthSeptember 24, 2025

Zydus Pharmaceuticals (USA) Inc — Entecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc.

⚠️ Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
September 24, 2025

Distributed Nationwide in the USA

What's affected?

Product
Entecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.
Lot code
E409308

Additional details

Lot#: E409308, Exp 12/31/2026

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 912 30-count bottles.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.